Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-26

Clinical Trial Update: The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy [NA]

View source ↗

Summary

A clinical trial update assessing whether thalidomide can prevent chemotherapy-induced nausea and vomiting caused by cisplatin-containing regimens, evaluating e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thalidomide (thalidomide)

Snippet

Sponsor: Yunpeng Liu | Conditions: Chemotherapy-induced Nausea and Vomiting | NA | Status: UNKNOWN